RICHARD PRICE: Open Payments
NPI 1104891407 · MONSEY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525,787 in 574 payments from 20 companies in 2025. Trend: 2023 $309,749 · 2024 $346,923 · 2025 $525,787
Speaker / faculty: $334,445Honoraria: $94,440Travel & lodging: $52,385Consulting: $32,557Food & beverage: $11,960
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 87 | $126,516 |
| Alkermes, Inc. | 91 | $105,551 |
| Axsome Therapeutics, Inc. | 70 | $66,293 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 42 | $40,659 |
| Supernus Pharmaceuticals, Inc. | 41 | $38,617 |
| Teva Pharmaceuticals USA, Inc. | 24 | $31,445 |
| Otsuka America Pharmaceutical, Inc. | 48 | $30,503 |
| ABBVIE INC. | 46 | $29,222 |
| Vanda Pharmaceuticals Inc. | 25 | $25,880 |
| Janssen Pharmaceuticals, Inc | 38 | $20,143 |
Products named: COBENFY, LYBALVI, Auvelity, CAPLYTA, Qelbree, UZEDY, ABILIFY MAINTENA, VRAYLAR.
Industry payments across NY — which companies pay providers there.
